<DOC>
	<DOC>NCT00930215</DOC>
	<brief_summary>The purpose of the study is to determine whether the HPMC capsule of D961H 40 mg is bioequivalent to gelatine capsules of D961H 40 mg after a steady state is reached on Day 5</brief_summary>
	<brief_title>Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese Classified as homoEM Negative for HIV, Hepatitis B, Hepatitis C and syphilis Significant clinical illness from 2 weeks preceding the preentry visit to the randomization Past or present cardiac, renal, hepatic, neurological or gastrointestinal disease</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Japanese males</keyword>
	<keyword>homo-EM</keyword>
	<keyword>Bioequivalence study</keyword>
</DOC>